4.7 Article

Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48 h after the start of treatment with pegylated interferon and ribavirin

Journal

ANTIVIRAL RESEARCH
Volume 88, Issue 1, Pages 124-127

Publisher

ELSEVIER
DOI: 10.1016/j.antiviral.2010.08.003

Keywords

HCV; Treatment; PEG-IFN and ribavirin; HCV-RNA decay; Early SVR prediction; EVR prediction

Funding

  1. Fondazione Camillo de Lellis per l'Innovazione e la Ricerca in Medicina, Pescara, Italy
  2. Pfizer Corp
  3. Astra-Zeneca
  4. Abbott
  5. Merck Sharp
  6. Dohme, Janssen Cilag, Virco

Ask authors/readers for more resources

The combination of pegylated interferons (PEG-IFNs) and ribavirin represents the standard of care for the treatment of chronic HCV-infected patients, yet with a success rate around 50% in genotypes 1 and 4, high costs and side effects. Therefore, early prediction of sustained virological response (SVR) is a relevant issue for HCV-patients. We evaluated the association between SVR and decline of HCV-RNA at 48 h in a prospective cohort of 145 HCV-patients treated with PEG-IFNs and ribavirin (males = 69.1%; genotypes 1/4 = 51.0%; HIV-1 coinfected = 6.7%). SVR was obtained in 65.5% of patients, while 16.6% experienced relapse and 17.9% no response. The first-phase of HCV-RNA decline clearly differentiated patients with SVR from relapsers and non-responders, independently of genotype (P < 0.001). In univariate and multivariate analyses, different infralogaritmic thresholds of HCV-RNA decay at 48 h were tested, observing the highest predictive potential at 0.5 log: decays above this threshold showed a 76.2% negative predictive value for SVR, whereas decays >0.5 log indicated a 6.8 odds ratio (95% C.I.: 2.0-23.2) for SVR after controlling for genotype, baseline viremia, adherence to therapy and HIV coinfection. Decays beyond the 0.5 log threshold were also strongly associated with and highly predictive of early virological response (95.0% positive predictive value, P < 0.001). (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Diagnosis of COVID-19 in children guided by lack of fever and exposure to SARS-CoV-2

Marco Roversi, Umberto Raucci, Giuseppe Pontrelli, Stefania Ranno, Michela Ambrosi, Antonio Torelli, Mara Pisani, Luana Coltella, Livia Piccioni, Luna Colagrossi, Marilena Agosta, Barbara Scialanga, Antonino Reale, Carlo Federico Perno, Paolo Rossi, Alberto Villani

Summary: This study reviewed data of children tested for COVID-19 and found that children without fever or contact with infected individuals were SARS-CoV-2 negative, which could help save resources and improve care.

PEDIATRIC RESEARCH (2022)

Article Microbiology

Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections

Sara Terreri, Eva Piano Mortari, Maria Rosaria Vinci, Cristina Russo, Claudia Alteri, Christian Albano, Francesca Colavita, Giulia Gramigna, Chiara Agrati, Giulia Linardos, Luana Coltella, Luna Colagrossi, Gloria Deriu, Marta Ciofi Degli Atti, Caterina Rizzo, Marco Scarsella, Rita Brugaletta, Vincenzo Camisa, Annapaola Santoro, Giuseppe Roscilli, Emiliano Pavoni, Alessia Muzi, Nicola Magnavita, Rossana Scutari, Alberto Villani, Massimiliano Raponi, Franco Locatelli, Carlo Federico Perno, Salvatore Zaffina, Rita Carsetti

Summary: This study investigated the long-term and functional B cell memory induced by the BNT162b2 mRNA vaccine against SARS-CoV-2 in healthcare workers. While specific antibodies declined over time, memory B cells persisted and increased, and breakthrough infections did not show signs of waning immunity.

CELL HOST & MICROBE (2022)

Article Infectious Diseases

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries

Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, Daniele Armenia, Desire Takou, Beatrice Dambaya, Georges Teto, Collins Ambe Chenwi, Alex Durant Nka, Grace Angong Beloumou, Sandrine Claire Djupsa Ndjeyep, Michel Carlos Tommo Tchouaket, Nadine Fainguem, Samuel Martin Sosso, Vittorio Colizzi, Carlo-Federico Perno, Alexis Ndjolo, Francesa Ceccherini-Silberstein, Maria Mercedes Santoro

Summary: This study developed and validated an integrase genotyping protocol on plasma samples from 195 HIV-infected patients in low and middle-income countries (LMICs). The protocol showed high effectiveness in genotyping both pure and recombinant viral clades, even at low-level viremia.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2022)

Article Infectious Diseases

Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in Italy

Marilena Agosta, Daniela Bencardino, Marta Argentieri, Laura Pansani, Annamaria Sisto, Marta Luisa Ciofi Degli Atti, Carmen D'Amore, Lorenza Putignani, Pietro Bagolan, Barbara Daniela Iacobelli, Andrea Dotta, Ludovica Martini, Luca Di Chiara, Mauro Magnani, Carlo Federico Perno, Francesca Andreoni, Paola Bernaschi

Summary: The spread of carbapenemase-producing Enterobacterales (CPE) is a serious public health threat in pediatric hospitals, especially among newborns who have underdeveloped immune systems and limited treatment options. This study aimed to estimate the prevalence and circulation of CPE in neonatal intensive units of a major pediatric hospital in Italy, and investigate their molecular features. The findings showed that the majority of CPE strains were multidrug-resistant and carried the bla(NDM) gene. There was also a high heterogeneity of CPE strains circulating in neonatal units, with some sharing the same circulating clone.

ANTIBIOTICS-BASEL (2022)

Article Public, Environmental & Occupational Health

Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study

Maria Elena Flacco, Graziella Soldato, Cecilia Acuti Martellucci, Giuseppe Di Martino, Roberto Carota, Antonio Caponetti, Lamberto Manzoli

Summary: Current data suggests that SARS-CoV-2 reinfections are rare, but uncertainties remain regarding the duration of natural immunity, its protection against the Omicron variant, and the impact of vaccination on reducing reinfection rates. A retrospective cohort analysis of the entire population of an Italian region followed over 1.2 million subjects and found a reinfection rate of 6.1 parts per thousand after an average of 277 days. Importantly, this reinfection rate did not significantly vary over time, suggesting that natural immunity may last beyond 12 months. The risk of reinfection was higher among females, unvaccinated individuals, and during the Omicron wave.

FRONTIERS IN PUBLIC HEALTH (2022)

Review Medicine, General & Internal

Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis

Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, Corrado De Vito, Erika Renzi, Paolo Villari, Lamberto Manzoli

Summary: This meta-analysis study suggests that the risk of SARS-CoV-2 reinfections is relatively low, but has increased during the first three months of the Omicron wave. There is a strong natural immunity following primary infection, which may last for more than one year. The risk and healthcare needs of recovered individuals might be limited.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Chemistry, Applied

Occurrence and congener profiles of dioxins (PCDDs), furans (PCDFs) and polychlorinated biphenyls (PCBs) in ovine and caprine milk samples collected in a very polluted site in Central Italy

Federica Castellani, Federico Marini, Giulia Simonetti, Carmela Protano, Leila Fabiani, Lamberto Manzoli, Matteo Vitali

Summary: Concentrations of 7 PCDDs, 10 PCDFs and 18 PCBs were measured in 16 milk samples from sheep and goats in Bussi sul Tirino, central Italy. The samples complied with the maximum levels set in EU regulations for PCDD/Fs and the sum of PCDD/Fs and DL-PCBs. However, in two cases, contamination levels of the sum of PCDD/Fs and DL-PCBs exceeded the action levels recommended by the EU. The contamination profiles of the milk samples were independent of the distance from the illegal landfill but likely influenced by local emission sources.

FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT (2023)

Article Immunology

COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province

Maria Elena Flacco, Cecilia Acuti Martellucci, Graziella Soldato, Giuseppe Di Martino, Roberto Carota, Marco De Benedictis, Graziano Di Marco, Giustino Parruti, Rossano Di Luzio, Antonio Caponetti, Lamberto Manzoli

Summary: This cohort study examined the incidence of potentially vaccine-related serious adverse events (PVR-SAEs) in the entire population of an Italian Province based on COVID-19 vaccination status. The findings showed that vaccinated individuals did not have an increased risk of death or PVR-SAEs compared to the unvaccinated. These results were consistent across different demographics, vaccine types, and infection statuses. Further research is needed to assess the long-term safety of COVID-19 vaccines.

VACCINES (2023)

Review Medicine, General & Internal

COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis

Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, Corrado De Vito, Erika Renzi, Paolo Villari, Lamberto Manzoli

Summary: This meta-analysis provides solid evidence that vaccination reduces the risk of SARS-CoV-2 reinfection and severe disease. The results are consistent across different studies and follow-up periods of up to 12 months.

FRONTIERS IN MEDICINE (2022)

Review Medicine, General & Internal

Inadvertent intrathecal drug injection while treating low back pain: a case report and review of the literature

Alessandro Ferrieri, Donatella Bosco, Ennio Polilli, Raffaella Ciulli, Lina Visocchi, Lucrezia Mincione, Rosa Iacoe, Rosamaria Zocaro, Antonella Frattari

Summary: This case report presents a rare case of inadvertent intrathecal injection of thiocolchicoside in a healthy woman with persistent low back pain. The patient experienced rapid neurological deterioration after the injection. This highlights the importance of administering injection therapy for low back pain in appropriate settings to promptly address possible complications.

JOURNAL OF MEDICAL CASE REPORTS (2023)

Article Virology

Predictors of SARS-CoV-2 Infection and Severe and Lethal COVID-19 after Three Years of Follow-Up: A Population-Wide Study

Maria Elena Flacco, Cecilia Acuti Martellucci, Graziella Soldato, Giuseppe Di Martino, Annalisa Rosso, Roberto Carota, Marco De Benedictis, Graziano Di Marco, Rossano Di Luzio, Matteo Ricci, Antonio Caponetti, Davide Gori, Lamberto Manzoli

Summary: This cohort study in Italy found that females, older individuals, and those with diabetes, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), kidney disease, and cancer were at a higher risk of SARS-CoV-2 infection. The likelihood of severe or lethal COVID-19 was significantly lower among younger individuals, while comorbidities were independently associated with a higher risk. Vaccination, especially with booster doses, significantly reduced the risk of severe or lethal disease.

VIRUSES-BASEL (2023)

Review Medicine, General & Internal

Cervical cerclage for prevention of preterm birth and adverse perinatal outcome in twin pregnancies with short cervical length or cervical dilatation: A systematic review and meta-analysis

Francesco D'Antonio, Nashwa Eltaweel, Smriti C. Prasad, Maria Elena C. Flacco, Lamberto C. Manzoli, Asma C. Khalil

Summary: This systematic review and meta-analysis aimed to evaluate the role of cervical cerclage in preventing preterm birth and adverse outcomes in twin pregnancies. The findings suggest that cervical cerclage in twin pregnancies with short cervical length or cervical dilatation is associated with a reduced risk of preterm birth and improved neonatal outcomes. However, confirmation of these findings in large and well-designed randomized controlled trials is needed for stronger evidence.

PLOS MEDICINE (2023)

Article Immunology

COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up

Annalisa Rosso, Maria Elena Flacco, Graziella Soldato, Giuseppe Di Martino, Cecilia Acuti Martellucci, Roberto Carota, Marco De Benedictis, Graziano Di Marco, Rossano Di Luzio, Matteo Fiore, Antonio Caponetti, Lamberto Manzoli

Summary: A cohort study was conducted in the province of Pescara, Italy, to assess the real-world effectiveness of SARS-CoV-2 vaccination. The study found that individuals who received at least one booster dose had an 85% lower risk of severe or lethal COVID-19. Moreover, during the Omicron predominance period, only the group who received at least a booster dose showed a reduced risk of COVID-19-related death.

VACCINES (2023)

Meeting Abstract Hematology

MONOCYTE DISTRIBUTION WIDTH (MDW) AS EARLY SEPSIS INDICATOR IN THE EMERGENCY DEPARTMENT: A MONOCENTRIC PROSPECTIVE STUDY

Ennio Polilli, Giustino Parruti, Maria Chiara Anelli, Claudio Silveri, Antonella Lattanzio, Gilda Angelini, Elisabetta Jessica Esposito, Milena D'Amato, Fabrizio Carinci, Giancarlo Di Iorio

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023)

Article Gastroenterology & Hepatology

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

Anita Y. M. Howe, Chaturaka Rodrigo, Evan B. Cunningham, Mark W. Douglas, Julia Dietz, Jason Grebely, Stephanie Popping, Javier Alejandro Sfalcin, Milosz Parczewski, Christoph Sarrazin, Adolfo de Salazar, Ana Fuentes, Murat Sayan, Josep Quer, Midori Kjellin, Hege Kileng, Orna Mor, Johan Lennerstrand, Slim Fourati, Velia Chiara Di Maio, Vladimir Chulanov, Jean-Michel Pawlotsky, P. Richard Harrigan, Francesca Ceccherini-Silberstein, Federico Garcia

Summary: Drug resistance in HCV is common following DAA treatment failure, with newly identified and uncharacterized substitutions emerging. Multidrug resistance is prevalent in patients with virologic failures, especially those treated with first-generation DAAs. Older individuals with cirrhosis and those infected with genotypes 1b and 4 are more likely to select drug-resistant viruses. International collaborative efforts are needed to effectively manage drug resistance and prevent onward transmission of resistant viruses.

JHEP REPORTS (2022)

No Data Available